Abbott Laboratories (WBO:ABT)
€ 108.8 -0.92 (-0.84%) Market Cap: 190.09 Bil Enterprise Value: 197.21 Bil PE Ratio: 34.45 PB Ratio: 4.94 GF Score: 92/100

Q4 2019 Abbott Laboratories Earnings Call Transcript

Jan 22, 2020 / 02:30PM GMT
Release Date Price: €83.01 (+3.27%)
Operator

Good morning, and thank you for standing by. Welcome to Abbott's Fourth Quarter 2019 Earnings Conference Call. (Operator Instructions) This call is being recorded by Abbott. With the exception of any participants' questions asked during the question-and-answer session, the entire call, including the question-and-answer session, is material copyrighted by Abbott. It cannot be recorded or rebroadcast without Abbott's express written permission.

I would now like to introduce Mr. Scott Leinenweber, Vice President, Investor Relations, Licensing and Acquisitions.

Scott Michael Leinenweber
Abbott Laboratories - VP of IR

Good morning, and thank you for joining us. With me today are Miles White, Chairman of the Board and Chief Executive Officer; Robert Ford, President and Chief Operating Officer; and Brian Yoor, Executive Vice President, Finance and Chief Financial Officer. Miles will provide opening remarks. Brian will discuss our performance and outlook in more detail. Following their comments, we'll take your questions.

Before we get started, some

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot